ReviewCardiovascular diabetology2021

Sodium-glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes.

Dario Giugliano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.